An Insight into Neuropeptides Inhibitors in the Biology of Colorectal Cancer: Opportunity and Translational Perspectives

Neuropeptides are mainly secreted from the human central and peripheral nervous systems. Neuropeptides bind to its cognate rhodopsin-like G-protein coupled receptor (GPCR) and perform various physiological functions. Conventional cancer treatments in clinical practice still present many drawbacks du...

Full description

Bibliographic Details
Main Authors: Ankit Srivastava, Deeksha Rikhari, Biswajita Pradhan, Kaushik Kumar Bharadwaj, Antonio Gaballo, Alessandra Quarta, Mrutyunjay Jena, Sameer Srivastava, Andrea Ragusa
Format: Article
Language:English
Published: MDPI AG 2022-09-01
Series:Applied Sciences
Subjects:
Online Access:https://www.mdpi.com/2076-3417/12/18/8990
_version_ 1797491526321831936
author Ankit Srivastava
Deeksha Rikhari
Biswajita Pradhan
Kaushik Kumar Bharadwaj
Antonio Gaballo
Alessandra Quarta
Mrutyunjay Jena
Sameer Srivastava
Andrea Ragusa
author_facet Ankit Srivastava
Deeksha Rikhari
Biswajita Pradhan
Kaushik Kumar Bharadwaj
Antonio Gaballo
Alessandra Quarta
Mrutyunjay Jena
Sameer Srivastava
Andrea Ragusa
author_sort Ankit Srivastava
collection DOAJ
description Neuropeptides are mainly secreted from the human central and peripheral nervous systems. Neuropeptides bind to its cognate rhodopsin-like G-protein coupled receptor (GPCR) and perform various physiological functions. Conventional cancer treatments in clinical practice still present many drawbacks due to the lack of selectivity toward the target cell, drug-resistance, and side-effects, thus pushing for the development of new therapeutic agents and therapies. Recent research suggests that neuropeptides influence cancer cell proliferation, invasion, metastasis, and angiogenesis and, therefore, they could be exploited as a target for novel anticancer therapies. Very recently, targeted approaches that inhibit neuropeptides and their associated receptors are being developed in cancer treatment. This review focuses on various neuropeptides and their potential utility as drug targets by different inhibitors as a recently identified approach to cancer prevention, with particular emphasis on colorectal cancer.
first_indexed 2024-03-10T00:50:39Z
format Article
id doaj.art-2130e37f63cb4b98b06bf20ebb3212f4
institution Directory Open Access Journal
issn 2076-3417
language English
last_indexed 2024-03-10T00:50:39Z
publishDate 2022-09-01
publisher MDPI AG
record_format Article
series Applied Sciences
spelling doaj.art-2130e37f63cb4b98b06bf20ebb3212f42023-11-23T14:51:15ZengMDPI AGApplied Sciences2076-34172022-09-011218899010.3390/app12188990An Insight into Neuropeptides Inhibitors in the Biology of Colorectal Cancer: Opportunity and Translational PerspectivesAnkit Srivastava0Deeksha Rikhari1Biswajita Pradhan2Kaushik Kumar Bharadwaj3Antonio Gaballo4Alessandra Quarta5Mrutyunjay Jena6Sameer Srivastava7Andrea Ragusa8Department of Biotechnology, Motilal Nehru National Institute of Technology, Allahabad 211004, IndiaDepartment of Biotechnology, Motilal Nehru National Institute of Technology, Allahabad 211004, IndiaAlgal Biotechnology and Molecular Systematic Laboratory, Post Graduate Department of Botany, Berhampur University, Bhanja Bihar, Berhampur 760007, IndiaDepartment of Bioengineering and Technology, Guwahati University, Guwahati 781014, IndiaCNR-Nanotec, Institute of Nanotechnology, Via Monteroni, 73100 Lecce, ItalyCNR-Nanotec, Institute of Nanotechnology, Via Monteroni, 73100 Lecce, ItalyAlgal Biotechnology and Molecular Systematic Laboratory, Post Graduate Department of Botany, Berhampur University, Bhanja Bihar, Berhampur 760007, IndiaDepartment of Biotechnology, Motilal Nehru National Institute of Technology, Allahabad 211004, IndiaCNR-Nanotec, Institute of Nanotechnology, Via Monteroni, 73100 Lecce, ItalyNeuropeptides are mainly secreted from the human central and peripheral nervous systems. Neuropeptides bind to its cognate rhodopsin-like G-protein coupled receptor (GPCR) and perform various physiological functions. Conventional cancer treatments in clinical practice still present many drawbacks due to the lack of selectivity toward the target cell, drug-resistance, and side-effects, thus pushing for the development of new therapeutic agents and therapies. Recent research suggests that neuropeptides influence cancer cell proliferation, invasion, metastasis, and angiogenesis and, therefore, they could be exploited as a target for novel anticancer therapies. Very recently, targeted approaches that inhibit neuropeptides and their associated receptors are being developed in cancer treatment. This review focuses on various neuropeptides and their potential utility as drug targets by different inhibitors as a recently identified approach to cancer prevention, with particular emphasis on colorectal cancer.https://www.mdpi.com/2076-3417/12/18/8990neuropeptidereceptorinhibitorscancertherapeutic agentsbombesin
spellingShingle Ankit Srivastava
Deeksha Rikhari
Biswajita Pradhan
Kaushik Kumar Bharadwaj
Antonio Gaballo
Alessandra Quarta
Mrutyunjay Jena
Sameer Srivastava
Andrea Ragusa
An Insight into Neuropeptides Inhibitors in the Biology of Colorectal Cancer: Opportunity and Translational Perspectives
Applied Sciences
neuropeptide
receptor
inhibitors
cancer
therapeutic agents
bombesin
title An Insight into Neuropeptides Inhibitors in the Biology of Colorectal Cancer: Opportunity and Translational Perspectives
title_full An Insight into Neuropeptides Inhibitors in the Biology of Colorectal Cancer: Opportunity and Translational Perspectives
title_fullStr An Insight into Neuropeptides Inhibitors in the Biology of Colorectal Cancer: Opportunity and Translational Perspectives
title_full_unstemmed An Insight into Neuropeptides Inhibitors in the Biology of Colorectal Cancer: Opportunity and Translational Perspectives
title_short An Insight into Neuropeptides Inhibitors in the Biology of Colorectal Cancer: Opportunity and Translational Perspectives
title_sort insight into neuropeptides inhibitors in the biology of colorectal cancer opportunity and translational perspectives
topic neuropeptide
receptor
inhibitors
cancer
therapeutic agents
bombesin
url https://www.mdpi.com/2076-3417/12/18/8990
work_keys_str_mv AT ankitsrivastava aninsightintoneuropeptidesinhibitorsinthebiologyofcolorectalcanceropportunityandtranslationalperspectives
AT deeksharikhari aninsightintoneuropeptidesinhibitorsinthebiologyofcolorectalcanceropportunityandtranslationalperspectives
AT biswajitapradhan aninsightintoneuropeptidesinhibitorsinthebiologyofcolorectalcanceropportunityandtranslationalperspectives
AT kaushikkumarbharadwaj aninsightintoneuropeptidesinhibitorsinthebiologyofcolorectalcanceropportunityandtranslationalperspectives
AT antoniogaballo aninsightintoneuropeptidesinhibitorsinthebiologyofcolorectalcanceropportunityandtranslationalperspectives
AT alessandraquarta aninsightintoneuropeptidesinhibitorsinthebiologyofcolorectalcanceropportunityandtranslationalperspectives
AT mrutyunjayjena aninsightintoneuropeptidesinhibitorsinthebiologyofcolorectalcanceropportunityandtranslationalperspectives
AT sameersrivastava aninsightintoneuropeptidesinhibitorsinthebiologyofcolorectalcanceropportunityandtranslationalperspectives
AT andrearagusa aninsightintoneuropeptidesinhibitorsinthebiologyofcolorectalcanceropportunityandtranslationalperspectives
AT ankitsrivastava insightintoneuropeptidesinhibitorsinthebiologyofcolorectalcanceropportunityandtranslationalperspectives
AT deeksharikhari insightintoneuropeptidesinhibitorsinthebiologyofcolorectalcanceropportunityandtranslationalperspectives
AT biswajitapradhan insightintoneuropeptidesinhibitorsinthebiologyofcolorectalcanceropportunityandtranslationalperspectives
AT kaushikkumarbharadwaj insightintoneuropeptidesinhibitorsinthebiologyofcolorectalcanceropportunityandtranslationalperspectives
AT antoniogaballo insightintoneuropeptidesinhibitorsinthebiologyofcolorectalcanceropportunityandtranslationalperspectives
AT alessandraquarta insightintoneuropeptidesinhibitorsinthebiologyofcolorectalcanceropportunityandtranslationalperspectives
AT mrutyunjayjena insightintoneuropeptidesinhibitorsinthebiologyofcolorectalcanceropportunityandtranslationalperspectives
AT sameersrivastava insightintoneuropeptidesinhibitorsinthebiologyofcolorectalcanceropportunityandtranslationalperspectives
AT andrearagusa insightintoneuropeptidesinhibitorsinthebiologyofcolorectalcanceropportunityandtranslationalperspectives